{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:53:10Z","timestamp":1761519190608,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T00:00:00Z","timestamp":1493683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004082","name":"Korean Foundation for Cancer Research","doi-asserted-by":"publisher","award":["CB-2011-03-02"],"award-info":[{"award-number":["CB-2011-03-02"]}],"id":[{"id":"10.13039\/501100004082","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12020-017-1307-4","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T10:52:10Z","timestamp":1493722330000},"page":"115-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The relationship of 19 functional polymorphisms in iodothyronine deiodinase and psychological well-being in hypothyroid patients"],"prefix":"10.1007","volume":"57","author":[{"given":"Yoon","family":"Young Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye","family":"Jeong Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye","family":"Won Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae","family":"Hyuk Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Seok","family":"Ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun","family":"Wook Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae","family":"Hoon Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"key":"1307_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldr030","volume":"99","author":"MP Vanderpump","year":"2011","unstructured":"M.P. Vanderpump, The epidemiology of thyroid disease. Br. Med. Bull. 99, 39\u201351 (2011). doi:\n                    10.1093\/bmb\/ldr030","journal-title":"Br. Med. Bull."},{"key":"1307_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3803\/EnM.2015.30.3.288","volume":"30","author":"GH Seo","year":"2015","unstructured":"G.H. Seo, J.H. Chung, Incidence and prevalence of overt hypothyroidism and causative diseases in Korea as determined using claims data provided by the health insurance review and assessment service. Endocrinol. Metab. 30, 288\u2013296 (2015). doi:\n                    10.3803\/EnM.2015.30.3.288","journal-title":"Endocrinol. Metab."},{"key":"1307_CR3","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1089\/thy.2014.0028","volume":"24","author":"J Jonklaas","year":"2014","unstructured":"J. Jonklaas, A.C. Bianco, A.J. Bauer, K.D. Burman, A.R. Cappola, F.S. Celi, D.S. Cooper, B.W. Kim, R.P. Peeters, M.S. Rosenthal, A.M. Sawka, Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 24, 1670\u20131751 (2014). doi:\n                    10.1089\/thy.2014.0028","journal-title":"Thyroid."},{"key":"1307_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000339444","volume":"1","author":"WM Wiersinga","year":"2012","unstructured":"W.M. Wiersinga, L. Duntas, V. Fadeyev, B. Nygaard, M.P. Vanderpump, 2012 ETA guidelines: the use of L-T4+L-T3 in the treatment of hypothyroidism. Eur. Thyroid. J. 1, 55\u201371 (2012). doi:\n                    10.1159\/000339444","journal-title":"Eur.Thyroid. J."},{"key":"1307_CR5","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archinte.160.4.526","volume":"160","author":"GJ Canaris","year":"2000","unstructured":"G.J. Canaris, N.R. Manowitz, G. Mayor, E.C. Ridgway, The Colorado thyroid disease prevalence study. Arch. Intern. Med. 160, 526\u2013534 (2000)","journal-title":"Arch. Intern. Med."},{"key":"1307_CR6","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nrendo.2015.155","volume":"11","author":"B Gereben","year":"2015","unstructured":"B. Gereben, E.A. McAninch, M.O. Ribeiro, A.C. Bianco, Scope and limitations of iodothyronine deiodinases in hypothyroidism. Nat. Rev. Endocrinol. 11, 642\u2013652 (2015). doi:\n                    10.1038\/nrendo.2015.155","journal-title":"Nat. Rev. Endocrinol."},{"key":"1307_CR7","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1172\/jci106304","volume":"49","author":"LE Braverman","year":"1970","unstructured":"L.E. Braverman, S.H. Ingbar, K. Sterling, Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J. Clin. Invest. 49, 855\u2013864 (1970). doi:\n                    10.1172\/jci106304","journal-title":"J. Clin. Invest."},{"key":"1307_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1056\/nejm199902113400603","volume":"340","author":"R Bunevicius","year":"1999","unstructured":"R. Bunevicius, G. Kazanavicius, R. Zalinkevicius, A.J. Prange Jr., Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N. Engl. J. Med. 340, 424\u2013429 (1999). doi:\n                    10.1056\/nejm199902113400603","journal-title":"N. Engl. J. Med."},{"key":"1307_CR9","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1530\/eje-09-0542","volume":"161","author":"B Nygaard","year":"2009","unstructured":"B. Nygaard, E.W. Jensen, J. Kvetny, A. Jarlov, J. Faber, Effect of combination therapy with thyroxine (T4) and 3,5,3\u2019-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study. Eur. J. Endocrinol. 161, 895\u2013902 (2009). doi:\n                    10.1530\/eje-09-0542","journal-title":"Eur. J. Endocrinol."},{"key":"1307_CR10","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1210\/jc.2004-1672","volume":"90","author":"P Saravanan","year":"2005","unstructured":"P. Saravanan, D.J. Simmons, R. Greenwood, T.J. Peters, C.M. Dayan, Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial. J. Clin. Endocrinol. Metab. 90, 805\u2013812 (2005). doi:\n                    10.1210\/jc.2004-1672","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1307_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/07435800903156340","volume":"34","author":"M Valizadeh","year":"2009","unstructured":"M. Valizadeh, M.R. Seyyed-Majidi, H. Hajibeigloo, S. Momtazi, N. Musavinasab, M.R. Hayatbakhsh, Efficacy of combined levothyroxine and liothyronine as compared with levothyroxine monotherapy in primary hypothyroidism: a randomized controlled trial. Endocr. Res. 34, 80\u201389 (2009). doi:\n                    10.1080\/07435800903156340","journal-title":"Endocr. Res."},{"key":"1307_CR12","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/jc.2008-1301","volume":"94","author":"V Panicker","year":"2009","unstructured":"V. Panicker, P. Saravanan, B. Vaidya, J. Evans, A.T. Hattersley, T.M. Frayling, C.M. Dayan, Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J. Clin. Endocrinol. Metab. 94, 1623\u20131629 (2009). doi:\n                    10.1210\/jc.2008-1301","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1307_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ajmg.b.31200","volume":"156B","author":"RA Philibert","year":"2011","unstructured":"R.A. Philibert, S.R. Beach, T.D. Gunter, A.A. Todorov, G.H. Brody, M. Vijayendran, L. Elliott, N. Hollenbeck, D. Russell, C. Cutrona, The relationship of deiodinase 1 genotype and thyroid function to lifetime history of major depression in three independent populations. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 156B, 593\u2013599 (2011). doi:\n                    10.1002\/ajmg.b.31200","journal-title":"Am. J. Med. Genet. B. Neuropsychiatr. Genet."},{"key":"1307_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 26, 1\u2013133 (2016). doi:\n                    10.1089\/thy.2015.0020","journal-title":"Thyroid."},{"key":"1307_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1399-0039.2011.01810.x","volume":"79","author":"H Jung","year":"2012","unstructured":"H. Jung, C.S. Ki, J.W. Kim, E.S. Kang, Frequencies of 10 autosomal minor histocompatibility antigens in Korean population and estimated disparities in unrelated hematopoietic stem cell transplantation. Tissue. Antigens. 79, 42\u201349 (2012). doi:\n                    10.1111\/j.1399-0039.2011.01810.x","journal-title":"Tissue. Antigens."},{"key":"1307_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr.","year":"1992","unstructured":"J.E. Ware Jr., C.D. Sherbourne, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care. 30, 473\u2013483 (1992)","journal-title":"Med. Care."},{"key":"1307_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s11136-004-1264-2","volume":"14","author":"YS Rhee","year":"2005","unstructured":"Y.S. Rhee, D.O. Shin, K.M. Lee, H.J. Yu, J.W. Kim, S.O. Kim, R. Lee, Y.O. Lee, N.S. Kim, Y.H. Yun, Korean version of the caregiver quality of life index-cancer (CQOLC-K). Qual. Life. Res. 14, 899\u2013904 (2005)","journal-title":"Qual. Life. Res."},{"key":"1307_CR18","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0895-4356(98)00108-5","volume":"51","author":"JE Ware Jr.","year":"1998","unstructured":"J.E. Ware Jr., B. Gandek, M. Kosinski, N.K. Aaronson, G. Apolone, J. Brazier, M. Bullinger, S. Kaasa, A. Leplege, L. Prieto, M. Sullivan, K. Thunedborg, The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J. Clin. Epidemiol. 51, 1167\u20131170 (1998)","journal-title":"J. Clin. Epidemiol."},{"key":"1307_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"A.S. Zigmond, R.P. Snaith, The hospital anxiety and depression scale. Acta. Psychiatr. Scand. 67, 361\u2013370 (1983)","journal-title":"Acta. Psychiatr. Scand."},{"key":"1307_CR20","first-page":"289","volume":"38","author":"SM Oh","year":"1999","unstructured":"S.M. Oh, K.J. Min, D.B. Park, A study on the standardization of the hospital anxiety and depression scale for Koreans: a comparison of normal, depressed and anxious groups. J. Korean Neuropsychiatr. Assoc. 38, 289\u2013296 (1999)","journal-title":"J. Korean Neuropsychiatr. Assoc."},{"key":"1307_CR21","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N","volume":"85","author":"TR Mendoza","year":"1999","unstructured":"T.R. Mendoza, X.S. Wang, C.S. Cleeland, M. Morrissey, B.A. Johnson, J.K. Wendt, S.L. Huber, The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer. 85, 1186\u20131196 (1999)","journal-title":"Cancer."},{"key":"1307_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jpainsymman.2004.04.013","volume":"29","author":"YH Yun","year":"2005","unstructured":"Y.H. Yun, X.S. Wang, J.S. Lee, J.W. Roh, C.G. Lee, W.S. Lee, K.S. Lee, S.M. Bang, T.R. Mendoza, C.S. Cleeland, Validation study of the korean version of the brief fatigue inventory. J. Pain. Symptom. Manage. 29, 165\u2013172 (2005). doi:\n                    10.1016\/j.jpainsymman.2004.04.013","journal-title":"J. Pain. Symptom. Manage."},{"key":"1307_CR23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1046\/j.1365-2265.2002.01654.x","volume":"57","author":"P Saravanan","year":"2002","unstructured":"P. Saravanan, W.F. Chau, N. Roberts, K. Vedhara, R. Greenwood, C.M. Dayan, Psychological well-being in patients on \u2018adequate\u2019 doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin. Endocrinol. 57, 577\u2013585 (2002)","journal-title":"Clin. Endocrinol."},{"key":"1307_CR24","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1210\/en.2006-1727","volume":"148","author":"VA Galton","year":"2007","unstructured":"V.A. Galton, E.T. Wood, E.A. StGermain, C.A. Withrow, G. Aldrich, G.M. StGermain, A.S. Clark, D.L. St Germain, Thyroid hormone homeostasis and action in the type 2 deiodinase-deficient rodent brain during development. Endocrinology. 148, 3080\u20133088 (2007). doi:\n                    10.1210\/en.2006-1727","journal-title":"Endocrinology."},{"key":"1307_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/sj.mp.4000963","volume":"7","author":"M Bauer","year":"2002","unstructured":"M. Bauer, A. Heinz, P.C. Whybrow, Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol. Psychiatry. 7, 140\u2013156 (2002). doi:\n                    10.1038\/sj.mp.4000963","journal-title":"Mol. Psychiatry."},{"key":"1307_CR26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1210\/jc.2014-4092","volume":"100","author":"EA McAninch","year":"2015","unstructured":"E.A. McAninch, S. Jo, N.Z. Preite, E. Farkas, P. Mohacsik, C. Fekete, P. Egri, B. Gereben, Y. Li, Y. Deng, M.E. Patti, C. Zevenbergen, R.P. Peeters, D.C. Mash, A.C. Bianco, Prevalent polymorphism in thyroid hormone-activating enzyme leaves a genetic fingerprint that underlies associated clinical syndromes. J. Clin. Endocrinol. Metab. 100, 920\u2013933 (2015). doi:\n                    10.1210\/jc.2014-4092","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1307_CR27","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1210\/jc.2007-1067","volume":"93","author":"M Torlontano","year":"2008","unstructured":"M. Torlontano, C. Durante, I. Torrente, U. Crocetti, G. Augello, G. Ronga, T. Montesano, L. Travascio, A. Verrienti, R. Bruno, S. Santini, P. D\u2019Arcangelo, B. Dallapiccola, S. Filetti, V. Trischitta, Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients. J. Clin. Endocrinol. Metab. 93, 910\u2013913 (2008). doi:\n                    10.1210\/jc.2007-1067","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"1307_CR28","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/jc.2016-2587","volume":"102","author":"Maria Grazia Castagna","year":"2017","unstructured":"M.G. Castagna, M. Dentice, S. Cantara, R. Ambrosio, F. Maino, T. Porcelli, C. Marzocchi, C. Garbi, F. Pacini, D. Salvatore, DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients. J. Clin. Endocrinol. Metab. (2017). doi:\n                    10.1210\/jc.2016-2587","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"1307_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1089\/thy.2016.0199","volume":"27","author":"HJ Wouters","year":"2017","unstructured":"H.J. Wouters, H.C. van Loon, M.M. van der Klauw, M.F. Elderson, S.N. Slagter, A.M. Kobold, I.P. Kema, T.P. Links, J.V. van Vliet-Ostaptchouk, B.H. Wolffenbuttel, No effect of the Thr92Ala polymorphism of deiodinase-2 on thyroid hormone parameters, health-related quality of life, and cognitive functioning in a large population-based cohort study. Thyroid. 27, 147\u2013155 (2017). doi:\n                    10.1089\/thy.2016.0199","journal-title":"Thyroid."},{"key":"1307_CR30","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/j.1365-2265.2008.03420.x","volume":"70","author":"WM Deure van der","year":"2009","unstructured":"W.M. van der Deure, P.S. Hansen, R.P. Peeters, A.G. Uitterlinden, M. Fenger, K.O. Kyvik, L. Hegedus, T.J. Visser, The effect of genetic variation in the type 1 deiodinase gene on the interindividual variation in serum thyroid hormone levels: an investigation in healthy Danish twins. Clin. Endocrinol. 70, 954\u2013960 (2009). doi:\n                    10.1111\/j.1365-2265.2008.03420.x","journal-title":"Clin. Endocrinol."},{"key":"1307_CR31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1530\/eje-10-0419","volume":"163","author":"JM Dora","year":"2010","unstructured":"J.M. Dora, W.E. Machado, J. Rheinheimer, D. Crispim, A.L. Maia, Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis. Eur. J. Endocrinol. 163, 427\u2013434 (2010). doi:\n                    10.1530\/eje-10-0419","journal-title":"Eur. J. Endocrinol."},{"key":"1307_CR32","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1210\/jc.2005-0451","volume":"90","author":"BC Appelhof","year":"2005","unstructured":"B.C. Appelhof, R.P. Peeters, W.M. Wiersinga, T.J. Visser, E.M. Wekking, J. Huyser, A.H. Schene, J.G. Tijssen, W.J. Hoogendijk, E. Fliers, Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine\/3,5,3\u2019-triiodothyronine therapy. J. Clin. Endocrinol. Metab. 90, 6296\u20136299 (2005). doi:\n                    10.1210\/jc.2005-0451","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1307_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jad.2008.10.019","volume":"116","author":"R Cooper-Kazaz","year":"2009","unstructured":"R. Cooper-Kazaz, W.M. van der Deure, M. Medici, T.J. Visser, A. Alkelai, B. Glaser, R.P. Peeters, B. Lerer, Preliminary evidence that a functional polymorphism in type 1 deiodinase is associated with enhanced potentiation of the antidepressant effect of sertraline by triiodothyronine. J. Affect. Disord. 116, 113\u2013116 (2009). doi:\n                    10.1016\/j.jad.2008.10.019","journal-title":"J. Affect. Disord."},{"key":"1307_CR34","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.pharep.2016.04.019","volume":"68","author":"E Galecka","year":"2016","unstructured":"E. Galecka, M. Talarowska, M. Maes, K.P. Su, P. Gorski, J. Szemraj, Polymorphisms of iodothyronine deiodinases (DIO1, DIO3) genes are not associated with recurrent depressive disorder. Pharmacol. Rep. 68, 913\u2013917 (2016). doi:\n                    10.1016\/j.pharep.2016.04.019","journal-title":"Pharmacol. Rep."},{"key":"1307_CR35","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1210\/jc.2008-0397","volume":"93","author":"V Panicker","year":"2008","unstructured":"V. Panicker, C. Cluett, B. Shields, A. Murray, K.S. Parnell, J.R. Perry, M.N. Weedon, A. Singleton, D. Hernandez, J. Evans, C. Durant, L. Ferrucci, D. Melzer, P. Saravanan, T.J. Visser, G. Ceresini, A.T. Hattersley, B. Vaidya, C.M. Dayan, T.M. Frayling, A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. J. Clin. Endocrinol. Metab. 93, 3075\u20133081 (2008). doi:\n                    10.1210\/jc.2008-0397","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1307_CR36","doi-asserted-by":"publisher","first-page":"E54","DOI":"10.1152\/ajpendo.2001.281.1.E54","volume":"281","author":"R Peeters","year":"2001","unstructured":"R. Peeters, C. Fekete, C. Goncalves, G. Legradi, H.M. Tu, J.W. Harney, A.C. Bianco, R.M. Lechan, P.R. Larsen, Regional physiological adaptation of the central nervous system deiodinases to iodine deficiency. Am. J. Physiol. Endocrinol. Metab. 281, E54\u2013E61 (2001)","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1307_CR37","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1365-2265.2011.04262.x","volume":"76","author":"FA Verburg","year":"2012","unstructured":"F.A. Verburg, J.W. Smit, I. Grelle, T.J. Visser, R.P. Peeters, C. Reiners, Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy. Clin. Endocrinol. 76, 577\u2013581 (2012). doi:\n                    10.1111\/j.1365-2265.2011.04262.x","journal-title":"Clin. Endocrinol."},{"key":"1307_CR38","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.pnpbp.2009.05.003","volume":"33","author":"B He","year":"2009","unstructured":"B. He, J. Li, G. Wang, W. Ju, Y. Lu, Y. Shi, L. He, N. Zhong, Association of genetic polymorphisms in the type II deiodinase gene with bipolar disorder in a subset of Chinese population. Prog. Neuropsychopharmacol. Biol. Psychiatry. 33, 986\u2013990 (2009). doi:\n                    10.1016\/j.pnpbp.2009.05.003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1307-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1307-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1307-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T16:36:37Z","timestamp":1568910997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-017-1307-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1307"],"URL":"https:\/\/doi.org\/10.1007\/s12020-017-1307-4","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"type":"print","value":"1355-008X"},{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2017,5,2]]},"assertion":[{"value":"17 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study was approved by the institutional research committee and informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}